We are live on
!
Find out more
GQG Partners Portfolio holdings
AUM
$53.8B
1-Year Est. Return
19.23%
This Fund
S&P 500
This Quarter
Est. Return
+18.68%
1 Year Est. Return
+19.23%
3 Year Est. Return
+225.42%
5 Year Est. Return
+476.53%
10 Year Est. Return
–
AUM
$34B
AUM Growth
+$6.65B
(+24%)
Cap. Flow
+$2.52B
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
50.6%
Holding
90
New
23
Increased
37
Reduced
18
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras
PBR
|
+$1.36B |
| 2 |
NVIDIA
NVDA
|
+$1.11B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.05B |
| 4 |
ExxonMobil
XOM
|
+$851M |
| 5 |
Alibaba
BABA
|
+$738M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$1.65B |
| 2 |
Abbott
ABT
|
+$1.49B |
| 3 |
Procter & Gamble
PG
|
+$847M |
| 4 |
Chevron
CVX
|
+$556M |
| 5 |
CMS Energy
CMS
|
+$373M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.56% |
| 2 | Communication Services | 18.4% |
| 3 | Financials | 14.44% |
| 4 | Healthcare | 10.36% |
| 5 | Energy | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
76
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $278K | ﹤0.01% |
+2,968
| New | +$273K |
|
|
CTLT
77
DELISTED
CATALENT, INC.
CTLT
| $273K | ﹤0.01% |
+2,524
| New | +$271K |
|
78
TotalEnergies
TTE
$191B
| $255K | ﹤0.01% |
+5,644
| New | +$264K |
|
79
Yum China
YUMC
$15.3B
| $249K | ﹤0.01% |
3,765
-1,546,729
| -100% | -$98.7M |
|
|
AMED
80
DELISTED
Amedisys
AMED
| $243K | ﹤0.01% |
+991
| New | +$260K |
|
81
Algonquin Power & Utilities
AQN
$4.36B
| – | – |
-7,803,198
| Closed | -$124M |
|
82
Atmos Energy
ATO
$28.2B
| – | – |
-537,911
| Closed | -$53.2M |
|
|
83
CMS Energy
CMS
$21.4B
| – | – |
-6,091,040
| Closed | -$373M |
|
84
New Oriental
EDU
$9.36B
| – | – |
-2,284,496
| Closed | -$320M |
|
|
85
JD.com
JD
$38.8B
| – | – |
-19,549,530
| Closed | -$1.65B |
|
86
3M
MMM
$89.9B
| – | – |
-539,952
| Closed | -$87M |
|
|
87
Procter & Gamble
PG
$334B
| – | – |
-6,257,808
| Closed | -$847M |
|
88
Royalty Pharma
RPRX
$27.1B
| – | – |
-7,902
| Closed | -$345K |
|
89
Steris
STE
$22.8B
| – | – |
-1,073
| Closed | -$204K |
|
90
TAL Education Group
TAL
$6.62B
| – | – |
-2,364,479
| Closed | -$127M |
|
Similar funds
HF
GQG Partners's Q2 2021 Portfolio in Review
As of Q2 2021, GQG Partners held 90 positions worth $34B, up 24% from $27.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
GQG Partners deployed $2.52B of net new capital in Q2 2021, opening 23 new positions and adding to 37 existing holdings. Its largest new stake was Petrobras: 138,947,266 shares worth $1.7B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Abbott, an estimated $1.49B trimmed.
- GQG Partners's largest Q2 2021 buy was Petrobras: 138,947,266 shares worth $1.7B.
- GQG Partners added most to NVIDIA in Q2 2021, an estimated $1.11B increase.
- GQG Partners's biggest Q2 2021 reduction was Abbott, cutting an estimated $1.49B.
- GQG Partners fully exited JD.com in Q2 2021, selling an estimated $1.65B.
- GQG Partners's ten largest holdings make up 51% of its $34B portfolio in Q2 2021.
- GQG Partners opened 23 new positions and closed 10 in Q2 2021.
- GQG Partners's portfolio value rose 24% quarter-over-quarter to $34B.
Based on GQG Partners's 13F filing for Q2 2021, filed 13 Aug 2021.